4D-310 in Adults With Fabry Disease and Cardiac Involvement
Clinical trial NCT05629559 · RECRUITING
Trial details
- NCT number
- NCT05629559
- Sponsor
- 4D Molecular Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-16
- Primary completion
- 2026-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.